牛牛AI助理已提取核心訊息
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of iBio Inc's common stock. The filing, dated February 13, 2024, shows that The Vanguard Group now beneficially owns 8,439 shares of iBio Inc, which represents 0.23% of the company's class of common stock. This position is a result of shared dispositive power over 152 shares and sole dispositive power over 8,287 shares. The Vanguard Group, based in Pennsylvania, has declared that the acquisition of these shares is for investment purposes and not with the intent to change or influence the control of iBio Inc. The filing confirms that The Vanguard Group's clients have the right to receive dividends or proceeds from the sale of these securities, and no single client's interest exceeds 5% of the class.
On December 29, 2023, The Vanguard Group filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of iBio Inc's common stock. The filing, dated February 13, 2024, shows that The Vanguard Group now beneficially owns 8,439 shares of iBio Inc, which represents 0.23% of the company's class of common stock. This position is a result of shared dispositive power over 152 shares and sole dispositive power over 8,287 shares. The Vanguard Group, based in Pennsylvania, has declared that the acquisition of these shares is for investment purposes and not with the intent to change or influence the control of iBio Inc. The filing confirms that The Vanguard Group's clients have the right to receive dividends or proceeds from the sale of these securities, and no single client's interest exceeds 5% of the class.
2023年12月29日，Vanguard集團向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的iBio Inc普通股發生了變化。這份日期爲2024年2月13日的文件顯示，先鋒集團現在實益擁有iBio Inc的8,439股股份，佔該公司普通股類別的0.23％。該地位是對152股股票的共同處置權和對8,287股的唯一處置權的結果。總部位於賓夕法尼亞州的Vanguard Group宣佈，收購這些股票是出於投資目的，無意改變或影響iBio Inc.的控制權。該文件證實，Vanguard Group的客戶有權獲得出售這些證券的股息或收益，任何一個客戶的利息都不超過該類別的5％。
2023年12月29日，Vanguard集團向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的iBio Inc普通股發生了變化。這份日期爲2024年2月13日的文件顯示，先鋒集團現在實益擁有iBio Inc的8,439股股份，佔該公司普通股類別的0.23％。該地位是對152股股票的共同處置權和對8,287股的唯一處置權的結果。總部位於賓夕法尼亞州的Vanguard Group宣佈，收購這些股票是出於投資目的，無意改變或影響iBio Inc.的控制權。該文件證實，Vanguard Group的客戶有權獲得出售這些證券的股息或收益，任何一個客戶的利息都不超過該類別的5％。
有用
沒用